Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma

Author:

Chevalier Benjamin12ORCID,Karleskind Oriane3,Jannin Arnaud12,Farchi Olivier4,Vermaut Catherine4,Escande Alexandre56,Baillet Clio7,Espiard Stéphanie128,Vantyghem Marie-Christine128,Carnaille Bruno2,Leteurtre Emmanuelle239,Do Cao Christine1ORCID

Affiliation:

1. Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France

2. University of Lille, Lille, France

3. Department of Pathology, Lille University Hospital, Lille, France

4. Department of Biochemistry and Molecular Biology, Hormonology Metabolism Nutrition Oncology, Lille University Hospital, Lille, France

5. Academic Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center, Lille, France

6. CRIStAL UMR CNRS 9189, University of Lille, Villeneuve-d’Ascq, France

7. Department of Nuclear Medicine, Lille University Hospital, Lille, France

8. Institut National de la Santé et de la Recherche Médicale (INSERM), European Genomic Institute for Diabetes (EGID), CHU Lille, Lille, France

9. University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France

Abstract

Introduction Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid cancer with a bleak prognosis. Favorable outcomes are rare but help decipher molecular pathophysiology, investigate prognosis factors, and discover new therapeutic targets. Case presentation Two patients were diagnosed with locally advanced nonresectable ATC, one with metastatic extension. Each patient received chemotherapy and radiotherapy, allowing thyroid surgical resection. In both cases, the pathological examination was consistent with complete response with no viable tumor cells. After follow-ups of 48 and 70 months, both patients remain disease-free. Molecular explorations on thyroid biopsies revealed microsatellite instability (MSI) and alterations on mismatch repair–gene complex, also PTEN and ATM variants in both cases. Both also presented with non-classical immune infiltrate composed of equal parts T CD4+ lymphocytes and macrophages. Conclusion We report two cases of patients cured from advanced ATC and for the first time provide genetic and immunological explorations in this setting. It seems with these two cases that MSI-ATCs may indicate a better prognosis. Our study hypothesizes different responsible mechanisms including increased sensitivity to chemoradiotherapy and/or immune tumor infiltrate modulation.

Publisher

Bioscientifica

Subject

Endocrinology, Diabetes and Metabolism

Reference50 articles.

1. Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survival;Glaser,2016

2. Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades;de Ridder,2020

3. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000–2019;Maniakas,2020

4. Anaplastic thyroid carcinoma: an update;Jannin,2022

5. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology;Richards,2015

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3